Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function tests

World Journal of Gastroenterology

Volumn 14, Issue 23, 2008, Pages 3710-3718

  You, Jing ^a   Sriplung, Hutcha ^a   Geater, Alan ^a   Chongsuvivatwong, Virasakdi ^a   Zhuang, Lin ^b   Chen, Hong Ying ^c   Huang, Jun Hua ^d   Tang, Bao Zhang ^c  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Third People's Hospital of Kunming   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d Yunnan General Hospital   (China)

Author keywords

Chronic hepatitis B virus infection; Hepatitis B virus; Hepatitis B virus DNA; Immune function; T lymphocyte subpopulation

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CHINESE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS REPLICATION;

EID: 54349106964     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3710     Document Type: Article

References (42)

1. World Health Organization, Department of Communicable diseases surveillance and response. Hepatitis B. WHO Fact Sheets. Available from: URL: http://www.who.int. Accessed: August 28, 2007
2. Pol S. [Natural history of hepatitis B infection] Presse Med 2006; 35: 308-316
3. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000; 15 Suppl: E3-E6
4. Baumert TF, Thimme R, von Weizsacker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007; 13: 82-90
5. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol 2006; 87: 1439-1449
6. Liu DX. A new hypothesis of pathogenetic mechanism of viral hepatitis B and C. Med Hypotheses 2001; 56: 405-408
7. Michalak TI, Hodgson PD, Churchill ND. Posttranscriptional inhibition of class 1 major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J Virol 2000; 74: 4483-4494
8. Khettry U, Anand N, Gordon FD, Jenkins RL, Tahan SR, Loda M, Lewis WD. Recurrent hepatitis B, hepatitis C, and combined hepatitis B and C in liver allografts: a comparative pathological study. Main Pathol 2000; 31: 11011-1108
9. Milich DR, Jones JF, Hughes JL, Price J, Raney AK, McLachlan A. is a function of the secreted hepatitis B e antigen to inducce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990; 87: 6599-6603
10. Milich DR. Do T cells "see" the hepatitis B core and e antigens differently? Gastroenterology 1999; 116: 765-768
11. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available from: URL: http://www.R-project.org. Assessed: August, 2007
12. Wang KX, Peng JL, Wang XF, Tian Y, Wang J, Li CP. Detection of T lymphocyte subsets and mIL-2R on surface of PBMC in patients with hepatitis B. World J Castroenterol 2003; 9: 2017-2020.
13. Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, Amlot PL, Williams R, Vergani D, Dusheiko GM, Bertoletti A. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000; 32: 1117-1124
14. Webster GJ, Reignat S, Brown D, Ogg GS, Jones L, Seneviratne SL, Williams R, Dusheiko G, Bertoletti A. Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2044; 78: 5707-5719
15. Sarin SK, Thakur V. Guptan RC, Saigal S. Malhotra V. Thyagarajan SP, Das BC. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol 2001; 16: 666-673
16. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? J Autoimmun 2000; 14: 1-10
17. Trobonjaca Z, Kroger A, Stober D, Leithauser F, Moller P, Hauser H, Schirmbeck R, Reimann J. Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. J immunol 2002; 168: 3763-3770
18. Rapicetta M, Ferrari C, Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol 2002; 67: 454-457
19. Tanner MS. Mechanisms of liver injury relevant to pediatric hepatology. Crit Rev Clin Lub Sci 2002; 39: 1-61
20. Rivero M, Crespo J, Fabrega E, Casafont F, Mayorga M, Gomez-Fleitas M, Pons-Romero F. Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. J Vira Hepat 2002, 9: 107-113
21. Okumura A. Ishikawa T, Yoshioka K, Yuasa R, Fukuzawa Y, Kakumu S. Mutation at codon 130 in hepatitis B virus (HBV) core region increases markedly during acute exacerbation of hepatitis in chronic HBV carriers. J Gastroenterol 2001; 36: 103-110
22. Tian Y, Qiu ZF, Li TS. [Difference and significance of peripheral blood T-lymphocyte subsets in patients with chronic hepatitis B and asymptomatic HBV carriers] Zhonghua Yixue Zazhi 2005; 85: 3354-3358
23. Chen M, Sallberg TA, Thung SN, Hughes J, Jones J, Milich DR. Nondeletional T-cell receptor transgenic mice: model for the CD4(+) T-cell repertoire in chronic hepatitis B virus infection. J Virol 2000; 74: 7587-7599
24. Lin CM, Wang FH. Selective modification of antigen-specific CD4(+) T cells by retroviral-mediated gene transfer and in vitro sensilization with dendritic cells. Clip Immunol 2002; 104: 58-66
25. Chen M, Sallberg M, Thung SN, Hughes J, Jones J, Milich DR. Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice. Antiviral Res 2001; 52: 99-111
26. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infecLion. J Virol 2003; 77; 68-76
27. Lau GK, Suri D, Liang R, Rigopoulou EL Thomas MG, Mullerova I, Nanji A, Yuen ST, Williams R, Naoumov NV. Resolution of chronic hepatitis B and anti-HBs serocorrversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterollogy 2002; 122; 614-624
28. Sing GK, Li D, Chen X, Macnaughton T, Lichanska AM, Butterworth L, Ladhams A, Cooksley G. A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B; evidence for antigen-driven selection of a public complementarity-determining region 3 (CDR3) motif. Hepatology 2001; 33: 1288-1298
29. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ. Kusters JG, Janssen HL. Regulatory T cells contribute to the impaired inumme response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771-778
30. Franzese O, Kennedy PT, Gehring AJ, Gotto J, Williams R, Maini MK, Bertoletti A. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005; 79: 3322-3328
31. Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle J H, Sette A, Rehermann B. Cellular immune responses to the hepatitis B virus polymerase. J Immunol 2004; 173: 5863-5871
32. Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, Boehme R, Panebianco R, Fiaccadori F, Ferrari C. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin invest 1998; 102: 968-975
33. Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, Cavalli A, Urbani S, Boehme R, Panebianco R, Fiaccadori F, Ferrari C. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33: 963-971
34. Boni C, Penna A, Bertoletti A, Lamonaca V, Rapti T, Missale G, Pilli M, Urbani S, Cavalli A, Cerioni S, Panebianco R, Jenkins J, Ferrari C. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol 2003; 39: 595-605
35. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, Bertoletti A, Ferrari C. Characterization of hepatitis B virus (HBV)-specitic T-cell dysfunction in chronic HBV infection. J Virol 20077; 81: 4215-4225
36. Pham BN, Mosnier iF, Walker F, Njapoum C, Bouggy F, Degott C, Erlinger S, Cohen JH, Degos F. Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B. Clin Exp Immunol 1994; 97: 403-410
37. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003; 38: 1075-1086
38. Chen MT, Billaud JN, Sallberg M. Guidotti LG, Chisari FV, Jones J, Hughes J, Milich DR. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci USA 2004; 101: 14913-14918
39. Chen M, Sallberg M. Hughes J. Jones J. Guidotti LG, Chisari FV, Billaud JN, Milich DR. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 2005; 79: 3016-3027
40. Liu CJ, Kao JH, Lai MY, Chen PJ, Chen DS. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. J Med Virol 2004; 72: 545-550
41. Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, Penna A, Giuberti T, Fiaccadori F, Ferrari C. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994; 180: 933-943
42. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M. Fiaccadori F. Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369: 407-410